Could giving TB pills on day one save more lives?
NCT ID NCT06739915
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new strategy: giving TB prevention medicine at the same time as TB testing to people with HIV starting or restarting antiretroviral therapy. The goal was to see if this approach gets more people on TB prevention quickly without missing active TB cases. The trial involved 364 adults in South Africa and compared this new method to standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
TB prevention medicine (TPT)
What this could lead to
If successful, this approach could help more people with HIV get TB prevention quickly, reducing TB cases in high-risk populations.
What could go wrong
This is a small pilot study (364 participants) in one country, so results may not apply elsewhere. Giving prevention medicine before ruling out active TB carries a small risk of delaying proper TB treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Perinatal HIV Research Unit
Soweto, Gauteng, 1864, South Africa